Integrated solutions for compliant 340B program management.

learn more

Comprehensive 340BPlus Solutions

Split Billing

Provides fully customizable, end-to-end 340B program management with a focus on program compliance.

learn more


A comprehensive self-audit solution to streamline workflow, quickly identify errors and omissions and implement processes to ensure 340B program compliance.

learn more

Contract Pharmacy

Our network helps to ensure 340B eligible patient compliance and access to competitively priced prescriptions.

learn more

The RxStrategies Difference

Integrated solutions that assist providers in meeting the challenges of maintaining a compliant 340B Drug Pricing Program.

View our 340B Solutions

Clinical Insights: February 13, 2018

Welcome to the weekly edition of RxStrategies Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place.   New Drug Approval Biktarvy® (bictegravir, emtricitabine and tenofovir alafenamide) – February 7, 2018 – Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Biktarvy®… Read more »


Stay Ahead of the Game at NACHC’s P&I 2018!

March 14-17, RxStrategies team members Rhodie Smith and Justin Rolling will be in Washington, D.C. for the National Association of Community Health Centers’ (NACHC) 2018 Policy and Issues Forum. Here, industry leaders will gather to offer unique insight to Members of Congress while offering solutions to current program regulations and legislative issues. Stay ahead of… Read more »